GT Biopharma logo
GT Biopharma
GTBP | NASDAQ
Chart Builder DCF Calculator
$3.54
-$0.18 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
+$0.07 (+1.98%)
After-hours: Nov 16, 2026, 6:41 PM ET

GT Biopharma Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-28.35M -13.16M -7.6M -20.88M -58.01M -28.3M
– – 13.58M – – 4K
432K 230K 2.2M 7.65M 33.93M 269K
377K -109K -137K 41K 863K 3.24M
15.93M -800K -18.86M 10K 538K 18.36M
– – – – – –
-920K 828K 1.83M -1.99M 7.94M 2.4M
-12.91M -12.9M -8.85M -15.22M -15.61M -7.26M
– – – – – –
– – – – – –
– 12.89M – 12.15M -23.04M –
– – – 12.15M – –
– – -2.01M -12.15M – –
– 12.89M -2.01M 12.15M -23.04M –
– – – – 1.21M 12.53M
– – – -224K – –
-229K – – – – –
– – – – 16.43M –
15.78M 2.98M 6.27M -224K 42.32M 12.53M
2.86M 2.97M -4.59M -3.3M 3.67M 5.27M
-12.91M -12.9M -8.85M -15.22M -15.61M -7.26M
-13.35M -13.13M -11.05M -22.86M -49.54M -7.53M
– – – – – –
– – – – – –
-12.91M -12.9M -8.85M -15.22M -15.61M -7.26M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.